JP2023548580A5 - - Google Patents

Info

Publication number
JP2023548580A5
JP2023548580A5 JP2023527226A JP2023527226A JP2023548580A5 JP 2023548580 A5 JP2023548580 A5 JP 2023548580A5 JP 2023527226 A JP2023527226 A JP 2023527226A JP 2023527226 A JP2023527226 A JP 2023527226A JP 2023548580 A5 JP2023548580 A5 JP 2023548580A5
Authority
JP
Japan
Prior art keywords
sequence
bacteriophage
phage
crispr
sequence identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023527226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548580A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/058095 external-priority patent/WO2022098899A1/en
Publication of JP2023548580A publication Critical patent/JP2023548580A/ja
Publication of JP2023548580A5 publication Critical patent/JP2023548580A5/ja
Pending legal-status Critical Current

Links

JP2023527226A 2020-11-05 2021-11-04 Crispr-cas系を含むエシェリキア属に対するファージ組成物およびその使用方法 Pending JP2023548580A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063110107P 2020-11-05 2020-11-05
US63/110,107 2020-11-05
US202163184647P 2021-05-05 2021-05-05
US63/184,647 2021-05-05
PCT/US2021/058095 WO2022098899A1 (en) 2020-11-05 2021-11-04 Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023548580A JP2023548580A (ja) 2023-11-17
JP2023548580A5 true JP2023548580A5 (enExample) 2024-11-13

Family

ID=81458374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527226A Pending JP2023548580A (ja) 2020-11-05 2021-11-04 Crispr-cas系を含むエシェリキア属に対するファージ組成物およびその使用方法

Country Status (6)

Country Link
US (1) US20230398161A1 (enExample)
EP (1) EP4247942A4 (enExample)
JP (1) JP2023548580A (enExample)
AU (1) AU2021372972A1 (enExample)
CA (1) CA3197277A1 (enExample)
WO (1) WO2022098899A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026150377A1 (en) 2025-01-13 2026-07-16 Locus Biosciences, Inc. Bacteriophage compositions and uses for treatment of escherichia coli (e. coli) colonization

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107208070B (zh) * 2014-11-26 2021-09-07 技术创新动力基金(以色列)有限合伙公司 细菌基因的靶向消除
AU2016280002B2 (en) * 2015-06-15 2022-04-14 North Carolina State University Methods and compositions for efficient delivery of nucleic acids and RNA-based antimicrobials
WO2017087909A1 (en) * 2015-11-19 2017-05-26 Epibiome, Inc. Bacteriophage compositions and methods of use thereof
US9896696B2 (en) * 2016-02-15 2018-02-20 Benson Hill Biosystems, Inc. Compositions and methods for modifying genomes
GB201710126D0 (en) * 2017-06-25 2017-08-09 Snipr Tech Ltd Vectors & Methods
US20230193241A1 (en) * 2017-06-25 2023-06-22 Snipr Technologies Limited Altering microbial populations & modifying microbiota
US20190160120A1 (en) * 2017-11-29 2019-05-30 Snipr Biome Aps Dna, methods etc
KR20210018273A (ko) * 2018-05-04 2021-02-17 로커스 바이오사이언스, 인크. 표적 박테리아를 사멸시키기 위한 방법 및 조성물
WO2019227080A1 (en) * 2018-05-25 2019-11-28 Locus Biosciences, Inc. Methods and compositions for killing a target bacterium
US20220370526A1 (en) * 2019-11-06 2022-11-24 Locus Biosciences, Inc. Phage compositions comprising crispr-cas systems and methods of use thereof
US20220411782A1 (en) * 2019-11-06 2022-12-29 Locus Biosciences, Inc. Phage compositions comprising crispr-cas systems and methods of use thereof

Similar Documents

Publication Publication Date Title
US12246061B2 (en) Sequence specific antimicrobials
Mesyanzhinov et al. The genome of bacteriophage φKZ of Pseudomonas aeruginosa
Miller et al. Bacteriophage T4 genome
Cazares et al. Core and accessory genome architecture in a group of Pseudomonas aeruginosa Mu-like phages
JP2019525914A5 (enExample)
US12378577B2 (en) Crispr-CAS10 systems and methods for phage genome editing
JP2008533988A5 (enExample)
JP2023548581A5 (enExample)
Innamorati et al. The bacterial guide to designing a diversified gene portfolio
EP4347809A1 (en) Rna-guided cas omega nucleases and uses thereof in diagnostics and therapy
Li et al. A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia
WO2025109112A1 (en) Engineered phagemids and methods for antibacterial peptide delivery against bacterial pathogens in particular clostridioides difficile
Stevens et al. The annotated complete DNA sequence of Enterococcus faecalis bacteriophage φEf11 and its comparison with all available phage and predicted prophage genomes
JP2010512774A (ja) バクテリオファージのスクリーニング蛋白質へのランダム配列挿入により改変されたバクテリオファージの作製方法
JP2010512774A5 (enExample)
Arbiol et al. Mobile regulatory cassettes mediate modular shuffling in T4-type phage genomes
Graham et al. Genomic analysis of an outbreak of toxin gene bearing Corynebacterium diphtheriae in Northern Queensland, Australia reveals high level of genetic similarity
WO2024173573A1 (en) Crispr-transposon systems and components
WO2020236741A2 (en) Synthetic bacteriophage and compositions and methods of selection and use
CN115960895B (zh) 一种偶联的crispr和毒素-抗毒素元件及其在消杀耐药细菌中的应用
Møller-Olsen et al. Advances in engineering of bacteriophages for therapeutic applications
WO2025029727A2 (en) Compositions, methods, and systems for dna modification
WO2023196220A2 (en) Method for genome-wide functional perturbation of human microsatellites using engineered zinc fingers
KR20060011602A (ko) HIV psi에 대한 결합력이 증가된 NC 돌연변이체및 이를 함유하는 약학적 조성물
CN121294546A (zh) 基于高性能A3F-BE4max的双AAV系统在治疗胰腺癌中的应用